Skip to main content
Veterinary Medicines

Synuclav Suspension for Injection

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate

Product identification

Medicine name:
Synuclav Suspension for Injection
CLAVOBAY SUSPENSION INJECTABLE
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Cattle
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Potassium clavulanate
    35.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Amoxicillin trihydrate
    140.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        42
        day
    • Cattle
      • Milk
        60
        hour
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • box containing 1 vial of 100 ml
  • box containing 1 vial of 50 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Laboratories (Ireland) Limited
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7057150 1/2004
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0354/001
Concerned member states:
  • Belgium
  • France
  • Iceland
  • Italy
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 23/03/2023
Download
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."